These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 22311406

  • 1. Effect of Feitai Capsule () on quality of life and progression-free survival of patients with unresectable non-small cell lung cancer.
    Yu ZY, Liu ZZ, Ouyang XN, Du J, Dai XH, Chen X, Zhao ZQ, Wang WW, Li J.
    Chin J Integr Med; 2012 Feb; 18(2):106-11. PubMed ID: 22311406
    [Abstract] [Full Text] [Related]

  • 2. [Effects of Feitai Capsule on quality of life in patients with advanced non-small-cell lung cancer: a randomized controlled trial].
    Liu ZZ, Yu ZY, Ouyang XN, Dai XH, Chen X, Zhao ZQ, Wang WW, Li J, Tu H, Ye L, Yan Y.
    Zhong Xi Yi Jie He Xue Bao; 2009 Jul; 7(7):611-5. PubMed ID: 19615313
    [Abstract] [Full Text] [Related]

  • 3. [Influence of Chinese herbal medicine Feitai Capsule on completion or delay of chemotherapy in patients with stage IIIB/IV non-small-cell lung cancer: a randomized controlled trial].
    Deng SQ, Ouyang XN, Yu ZY, Dai XH, Chen X, Fang FZ, Wang WW, Liu ZZ.
    Zhong Xi Yi Jie He Xue Bao; 2012 Jun; 10(6):635-40. PubMed ID: 22704411
    [Abstract] [Full Text] [Related]

  • 4. Chinese herbal medicine as maintenance therapy for improving the quality of life for advanced non-small cell lung cancer patients.
    Han Y, Wang H, Xu W, Cao B, Han L, Jia L, Xu Y, Zhang Q, Wang X, Zhang G, Yu M, Yang G.
    Complement Ther Med; 2016 Feb; 24():81-9. PubMed ID: 26860807
    [Abstract] [Full Text] [Related]

  • 5. Effect of gefitinib plus Chinese herbal medicine (CHM) in patients with advanced non-small-cell lung cancer: a retrospective case-control study.
    Yang XB, Wu WY, Long SQ, Deng H, Pan ZQ.
    Complement Ther Med; 2014 Dec; 22(6):1010-8. PubMed ID: 25453521
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of Aidi Injection () on overexpression of P-glycoprotein induced by vinorelbine and cisplatin regimen in patients with non-small cell lung cancer.
    Ma JJ, Liu HP.
    Chin J Integr Med; 2017 Jul; 23(7):504-509. PubMed ID: 27484766
    [Abstract] [Full Text] [Related]

  • 7. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Garassino MC, Gadgeel S, Esteban E, Felip E, Speranza G, Domine M, Hochmair MJ, Powell S, Cheng SY, Bischoff HG, Peled N, Reck M, Hui R, Garon EB, Boyer M, Wei Z, Burke T, Pietanza MC, Rodríguez-Abreu D.
    Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
    [Abstract] [Full Text] [Related]

  • 8. [Clinical study on treatment of advanced stage non-small cell lung cancer by guben xiaoliu capsule].
    Wang XM, Xin H, Yang Z, Zhao W, Yang G, Liu J, Tang W, Zhang Q, Han D, Yu R.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Nov; 24(11):986-8. PubMed ID: 15609595
    [Abstract] [Full Text] [Related]

  • 9. The effect of comprehensive rehabilitation program plus chemotherapy on quality of life in patients with postoperative non-small-cell lung cancer: study protocol of a multicenter randomized clinical trial.
    Yao J, Jiao L, Yao Y, Lu Y, Shi J, Li J, Chen P, Xu L, Gong Y.
    Trials; 2020 Apr 03; 21(1):309. PubMed ID: 32245480
    [Abstract] [Full Text] [Related]

  • 10. Gefitinib plus Fuzheng Kang'ai Formula () in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: A Randomized Controlled Trial.
    Yang XB, Chai XS, Wu WY, Long SQ, Deng H, Pan ZQ, He WF, Zhou YS, Liao GY, Xiao SJ.
    Chin J Integr Med; 2018 Oct 03; 24(10):734-740. PubMed ID: 28795387
    [Abstract] [Full Text] [Related]

  • 11. Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.
    Yang XB, Wu WY, Long SQ, Deng H, Pan ZQ, He WF, Zhou YS, Liao GY, Li QP, Xiao SJ, Cai JZ.
    Trials; 2015 Apr 10; 16():146. PubMed ID: 25873045
    [Abstract] [Full Text] [Related]

  • 12. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O'Brien M, Rao S, Hotta K, Zhang J, Lubiniecki GM, Deitz AC, Rangwala R, Reck M.
    Lancet Oncol; 2017 Dec 10; 18(12):1600-1609. PubMed ID: 29129441
    [Abstract] [Full Text] [Related]

  • 13. Systematic review and meta-analysis of Chinese herbal medicine as adjuvant treatment in advanced non-small cell lung cancer patients.
    Wang LC, Chang YY, Lee IC, Kuo HC, Tsai MY.
    Complement Ther Med; 2020 Aug 10; 52():102472. PubMed ID: 32951722
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation on effect of feiji recipe on quality of life of patients with non-small cell lung cancer by adopting international questionnaire of QOL].
    You J, Shi ZM, Han BH.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan 10; 26(1):33-7. PubMed ID: 16466169
    [Abstract] [Full Text] [Related]

  • 16. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].
    Yan GY, Xu ZY, Deng HB, Wan ZY, Zhang L, Zhu JY.
    Zhong Xi Yi Jie He Xue Bao; 2011 May 10; 9(5):525-30. PubMed ID: 21565138
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized clinical trials.
    Yang J, Zhu X, Yuan P, Liu J, Wang B, Wang G.
    Support Care Cancer; 2020 Aug 10; 28(8):3571-3579. PubMed ID: 32266566
    [Abstract] [Full Text] [Related]

  • 18. Comprehensive treatment with Chinese medicine in patients with advanced non-small cell lung cancer: A multicenter, prospective, cohort study.
    Liu J, Lin HS, Hou W, Hua BJ, Zhang PT, Li J, Wang SY, Xie Y, Zhang Y, Xie GR, Zhang MY, Shi WG, Guan NB, Guan TY, Li CH, Lu LY, Zhang Y, Li DR, Liu H.
    Chin J Integr Med; 2017 Oct 10; 23(10):733-739. PubMed ID: 27796823
    [Abstract] [Full Text] [Related]

  • 19. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
    Hui R, Özgüroğlu M, Villegas A, Daniel D, Vicente D, Murakami S, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Gray JE, Rydén A, Viviers L, Poole L, Zhang Y, Dennis PA, Antonia SJ.
    Lancet Oncol; 2019 Dec 10; 20(12):1670-1680. PubMed ID: 31601496
    [Abstract] [Full Text] [Related]

  • 20. Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer.
    Tan EH, Rolski J, Grodzki T, Schneider CP, Gatzemeier U, Zatloukal P, Aitini E, Carteni G, Riska H, Tsai YH, Abratt R.
    Ann Oncol; 2009 Jul 10; 20(7):1249-56. PubMed ID: 19276396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.